Author

H. Glimm

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Assay:bulk RNA-seq· 3 Organism:human· 3 Approach:experimental assay· 2 Organism:mouse· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:ChIP-seq· 1

Frequent Co-Authors

C. R. Ball· 3 shared C. Scholl· 2 shared T. Kindler· 2 shared A. A. Wurm· 1 shared A. Banito· 1 shared A. Carazzato· 1 shared A. M. Dobberkau· 1 shared A. Nilsson· 1 shared

Activity by Year

2019-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

C. R. Ball

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

The histone modifier KAT2A presents a selective target in a subset of well-differentiated microsatellite-stable colorectal cancers

V. Kufrin, A. Seiler, S. Brilloff, H. Rothfuss, S. Schuster, S. Schaefer, E. Rahimian, J. Baumgarten, C. R. Ball, M. Bornhaeuser, H. Glimm, M. Bill, A. A. Wurm

This study identifies KAT2A as a therapeutic target in a subset of well-differentiated, microsatellite-stable colorectal cancers by showing its dependency and functional consequences.

bioRxiv · Nov 15, 2023Cancer Biology

Multidimensional Characterization of Soft-Tissue Sarcomas with FUS-TFCP2 or EWSR1-TFCP2 Fusions

J. Schopf, S. Uhrig, C. E. Heilig, K.-S. Lee, T. Walther, A. Carazzato, A. M. Dobberkau, D. Weichenhan, C. Plass, M. Hartmann, G. D. Diwan, Z. Carrero, C. R. Ball, T. Hohl, T. Kindler, , C. Scholl

This study characterizes soft-tissue sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions through multi-omics analyses and functional studies, identifying therapeutic targets and mechanisms of disease.

bioRxiv · Feb 19, 2023Cancer Biology

Cell division tracing combined with single-cell transcriptomics reveals new cell types and differentiation paths in the regenerating mouse lung

L. R. Martins, L. Sieverling, M. Michelhans, C. Schiller, C. Erkut, S. Triana, S. Froehling, L. Velten, H. Glimm, C. Scholl

bioRxiv · Jan 18, 2023Cell Biology

YAP orchestrates heterotypic endothelial cell communication via HGF/c-MET signaling in liver tumorigenesis

S. Thomann, S. M. Weiler, S. Marquard, C. R. Ball, M. Toth, T. Wei, C. Sticht, C. de la Torre, E. Ryschich, O. Ermakova, C. Mogler, D. N. Kazdal, N. Gretz, H. Glimm, E. Rempel, , K. Breuhahn

This study shows YAP promotes liver tumor progression by altering the vascular niche, creating heterotypic communication between endothelial cell subtypes via HGF/c-MET signaling.

bioRxiv · Mar 17, 2020Cancer Biology

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC

C. Messerschmidt, B. Obermayer, K. Klinghammer, S. Ochsenreither, D. Treue, A. Stenzinger, H. Glimm, S. Fröhling, T. Kindler, C. H. Brandts, K. Schulze-Osthoff, W. Weichert, I. Tinhofer, F. Klauschen, U. Keilholz, , D. T. Rieke

The paper identifies an APOBEC-enriched subgroup of HPV-negative HNSCC with distinct immunogenic features linked to immune evasion and potential response to immunotherapy.

bioRxiv · Mar 28, 2019Cancer Biology